KALA BIO, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
KALA BIO, INC. (KALA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 377.60 thousand shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-04-15
- KALA BIO, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 377.60K shares, a 249.89% increase from fiscal 2024.
- KALA BIO, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 107.92K shares, a 46.87% decline from fiscal 2023.
- KALA BIO, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 203.12K shares, a 164.81% increase from fiscal 2022.
- KALA BIO, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 76.70K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|
| 2025-12-31 | 377.60K shares 10-K · filed 2026-04-15 |
| 2024-12-31 | 107.92K shares 10-K · filed 2025-03-31 |
| 2023-12-31 | 203.12K shares 10-K · filed 2024-03-29 |
| 2022-12-31 | 76.70K shares 10-K · filed 2023-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |